When a fever just won't go away
Imagine your child has been running a fever for days or weeks, but the doctors can't figure out why. You've done blood tests, cultures, and scans—all normal. The antibiotics don't seem to be helping. This frustrating situation is called a "fever of unknown origin" (FUO), and it's more common than you'd think in hospitals across Singapore and Asia.
The problem is that traditional methods of testing for infections—like growing bacteria in a lab or looking at samples under a microscope—can take days or even weeks to get results, and they don't always catch the culprit. A new genetic technology called metagenomic next-generation sequencing (mNGS) promises to change that. Recent research from China examined whether this advanced method could help solve these mystery fevers in children.
What the research found
Doctors tested 41 hospitalized children with unexplained fevers using mNGS alongside traditional testing methods. The results? The new genetic test identified infections in about half the cases, finding bacteria, viruses, fungi, and other pathogens that standard tests might have missed. Most importantly, when the new test did find something, it helped doctors change their treatment plans—adding antivirals for some children, switching antibiotics for others, or stopping unnecessary medications.
However—and this is crucial—mNGS was not significantly more accurate than traditional testing overall. Both methods found infections at similar rates. The real value lies in what happens when standard tests come back negative but your child is still very sick.
What this means for Singapore families
If your child develops a persistent unexplained fever in a Singapore hospital, doctors will continue to use traditional testing methods first. These remain the gold standard and are usually sufficient. However, if your child's fever lingers despite treatment, or if initial tests are negative but infection is still suspected, mNGS may be offered as an additional tool—similar to getting a second opinion.
This matters for Asian families because of travel patterns and the diverse infections circulating across the region. A child who has recently visited relatives in other parts of Asia might carry a rare pathogen that standard lab tests struggle to identify. mNGS's ability to scan for a broader spectrum of microbes could be particularly valuable in these cases.
The technology also reduces the time doctors spend guessing about treatment. Instead of trying multiple antibiotics while waiting for results, they can make more precise decisions faster—potentially sparing your child unnecessary medications and their side effects.
Three things to know as a parent
- mNGS is a backup tool, not a replacement. Your child's initial fever workup will still involve traditional blood tests and cultures. Think of mNGS as the detective called in when the first investigators hit a dead end—helpful, but not first in line.
- It helps doctors make faster, smarter treatment choices. When mNGS identifies a specific pathogen, doctors can adjust medicines immediately—either stopping unnecessary ones or adding targeted treatments—which means shorter hospital stays and fewer side effects.
- Ask about it if your child's fever remains unexplained after standard testing. If your child has been hospitalised with an undiagnosed fever for several days and conventional testing hasn't helped, it's worth asking your doctor whether mNGS testing might be appropriate.